News

Doctor signature requirement 'not delaying abortions'

07-Dec-07

The requirement for two doctors' signatures is not delaying abortions, according to the government.

Data for 2006 show that 68 per cent of abortions take place at less than 10 weeks and 89 per cent at less than 13 weeks, according to the government’s response to the Commons’ Science and Technology Committee’s report on abortion published last month.

The Committee recommended that the requirement be removed.

The government response added that : ‘Two hospitals are currently being funded by the DoH to run early medical abortion services in non-traditional settings to evaluate the effectivesness and safety of provision in these settings.’

The evaluation will be complete in 2008, when a decision on abortions in GP surgeries will be taken.

neil.durham@haymarket.com

Comment below and tell us what you think 

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Journals club - HPV vaccine

Curriculum statement 5. Healthy people: promoting health and preventing disease. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more

Jobs

 

Job of the Week